Merck gets is ‘One Less’ FDA Approval The FDA rejected Merck’s request to approve its HPV vaccine, Gardasil for women between ages 27 and 45, citing “issues that preclude approval within the expected review timeframe,” Merck offered no additional specific explanation in their … [Read more...] about FDA Thwarts Merck’s Expanded Use of Gardasil, For Now
Gardasil
BBC Reports Glaxo’s Very Profitable HPV Vaccine Contract With UK
The following BBC story diagrams the corporate infighting over which multi-national Pharma Giant wins the very profitable HPV vaccine contract with the UK public health department. Glaxo needed a win big time. Merck has effectively shut them out of the lucrative American market, … [Read more...] about BBC Reports Glaxo’s Very Profitable HPV Vaccine Contract With UK
Merck To Text Teens About Gardasil Reminders?
Merck’s ‘3 Is Key’ Campaign Goes Viral The drugmaker is urging docs to distribute a spiffy new brochure after administering the HPV vaccine in hopes teens and women will return for their second and third shots. However, the brochure, which is part of Merck’s ‘3 Is Key’ … [Read more...] about Merck To Text Teens About Gardasil Reminders?
The HPV Vaccine Public Relations Drum Beat Goes On
My Vaccine is Better than Your Vaccine” Merck and Glaxo PR hacks continue to deluge all media with “My Vaccine is Better than Your Vaccine” commercial jingles, youtube videos, interviews, dueling scientific papers, and lobby bucks, lots and lots of lobby bucks. It's no … [Read more...] about The HPV Vaccine Public Relations Drum Beat Goes On
Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market
Glaxo Still Chasing FDA Approval For Cervarix The FDA’s approval for the ‘other’ HPV-vaccine, Cervarix is still delayed. GlaxoSmithKline, the world's second-largest drugmaker, requested a 'priority' review, potentially prompting an approval decision and sale of the Cervarix … [Read more...] about Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market